Dynavax Technologies Analyst Ratings
Dynavax Technologies Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/03/2023 | 88.55% | HC Wainwright & Co. | $27 → $28 | Maintains | Buy |
| 08/04/2023 | 81.82% | HC Wainwright & Co. | → $27 | Reiterates | Buy → Buy |
| 08/04/2023 | 68.35% | JMP Securities | $24 → $25 | Maintains | Outperform |
| 05/03/2023 | 61.62% | JMP Securities | $25 → $24 | Maintains | Outperform |
| 05/03/2023 | 81.82% | HC Wainwright & Co. | → $27 | Reiterates | → Buy |
| 02/24/2023 | 68.35% | JMP Securities | $22 → $25 | Maintains | Market Outperform |
| 02/24/2023 | 81.82% | HC Wainwright & Co. | $28 → $27 | Maintains | Buy |
| 11/04/2022 | 41.41% | Goldman Sachs | $24 → $21 | Maintains | Buy |
| 09/27/2022 | 48.15% | JMP Securities | → $22 | Initiates Coverage On | → Market Outperform |
| 12/29/2021 | 88.55% | HC Wainwright & Co. | $23 → $28 | Maintains | Buy |
| 08/31/2021 | 54.88% | HC Wainwright & Co. | $20 → $23 | Maintains | Buy |
| 08/06/2021 | 27.95% | Goldman Sachs | → $19 | Initiates Coverage On | → Buy |
| 08/05/2021 | 34.68% | HC Wainwright & Co. | $16 → $20 | Maintains | Buy |
| 02/01/2021 | 1.01% | HC Wainwright & Co. | $14 → $15 | Maintains | Buy |
| 11/06/2020 | -5.72% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 08/07/2020 | -19.19% | HC Wainwright & Co. | $14 → $12 | Maintains | Buy |
| 08/03/2020 | -5.72% | HC Wainwright & Co. | $12 → $14 | Maintains | Buy |
| 03/12/2020 | -19.19% | HC Wainwright & Co. | $13 → $12 | Reiterates | → Buy |
| 10/18/2019 | -12.46% | HC Wainwright & Co. | → $13 | Initiates Coverage On | → Buy |
| 07/11/2019 | — | Cantor Fitzgerald | Upgrades | Neutral → Overweight | |
| 11/06/2018 | 68.35% | RBC Capital | $26 → $25 | Maintains | Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/03/2023 | 88.55% | HC Wainwright & Co. | 27 美元 → 28 美元 | 維護 | 買 |
| 08/04/2023 | 81.82% | HC Wainwright & Co. | → 27 美元 | 重申 | 購買 → 購買 |
| 08/04/2023 | 68.35% | JMP 證券 | 24 美元 → 25 美元 | 維護 | 跑贏大盤 |
| 05/03/2023 | 61.62% | JMP 證券 | 25 美元 → 24 美元 | 維護 | 跑贏大盤 |
| 05/03/2023 | 81.82% | HC Wainwright & Co. | → 27 美元 | 重申 | → 購買 |
| 02/24/2023 | 68.35% | JMP 證券 | 22 美元 → 25 美元 | 維護 | 市場表現跑贏大盤 |
| 02/24/2023 | 81.82% | HC Wainwright & Co. | 28 美元 → 27 美元 | 維護 | 買 |
| 2022 年 4 月 11 日 | 41.41% | 高盛 | 24 美元 → 21 美元 | 維護 | 買 |
| 09/27/2022 | 48.15% | JMP 證券 | → 22 美元 | 啓動覆蓋範圍開啓 | → 市場跑贏大盤 |
| 12/29/2021 | 88.55% | HC Wainwright & Co. | 23 美元 → 28 美元 | 維護 | 買 |
| 08/31/2021 | 54.88% | HC Wainwright & Co. | 20 美元 → 23 美元 | 維護 | 買 |
| 2021 年 6 月 8 日 | 27.95% | 高盛 | → 19 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 08/05/2021 | 34.68% | HC Wainwright & Co. | 16 美元 → 20 美元 | 維護 | 買 |
| 2021 年 1 月 2 日 | 1.01% | HC Wainwright & Co. | 14 美元 → 15 美元 | 維護 | 買 |
| 11/06/2020 | -5.72% | HC Wainwright & Co. | 12 美元 → 14 美元 | 維護 | 買 |
| 08/07/2020 | -19.19% | HC Wainwright & Co. | 14 美元 → 12 美元 | 維護 | 買 |
| 2020 年 3 月 8 日 | -5.72% | HC Wainwright & Co. | 12 美元 → 14 美元 | 維護 | 買 |
| 03/12/2020 | -19.19% | HC Wainwright & Co. | 13 美元 → 12 美元 | 重申 | → 購買 |
| 10/18/2019 | -12.46% | HC Wainwright & Co. | → 13 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2019 年 11 月 7 日 | — | 坎託·菲茨傑拉德 | 升級 | 中性 → 超重 | |
| 11/06/2018 | 68.35% | 加拿大皇家銀行資本 | 26 美元 → 25 美元 | 維護 | 跑贏大盤 |
What is the target price for Dynavax Technologies (DVAX)?
Dynavax Technologies (DVAX) 的目標價格是多少？
The latest price target for Dynavax Technologies (NASDAQ: DVAX) was reported by HC Wainwright & Co. on November 3, 2023. The analyst firm set a price target for $28.00 expecting DVAX to rise to within 12 months (a possible 88.55% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月3日公佈了戴納瓦克斯科技（納斯達克股票代碼：DVAX）的最新目標股價。該分析公司將目標股價定爲28.00美元，預計DVAX將在12個月內升至12個月內（可能上漲88.55％）。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Dynavax Technologies (DVAX)?
Dynavax Technologies (DVAX) 的最新分析師評級是多少？
The latest analyst rating for Dynavax Technologies (NASDAQ: DVAX) was provided by HC Wainwright & Co., and Dynavax Technologies maintained their buy rating.
HC Wainwright & Co. 提供了Dynavax Technologies（納斯達克股票代碼：DVAX）的最新分析師評級，Dynavax Technologies維持買入評級。
When is the next analyst rating going to be posted or updated for Dynavax Technologies (DVAX)?
Dynavax Technologies（DVAX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on November 3, 2023 so you should expect the next rating to be made available sometime around November 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Dynavax Technologies的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Dynavax Technologies的最新評級是在2023年11月3日發佈的，因此您應該預計下一個評級將在2024年11月3日左右公佈。
Is the Analyst Rating Dynavax Technologies (DVAX) correct?
分析師對Dynavax Technologies (DVAX) 的評級正確嗎？
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a maintained with a price target of $27.00 to $28.00. The current price Dynavax Technologies (DVAX) is trading at is $14.85, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的戴納瓦克斯科技（DVAX）評級維持不變，目標股價爲27.00美元至28.00美元。戴納瓦克斯科技（DVAX）目前的交易價格爲14.85美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。